These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16930112)

  • 1. Heparin: the cheap alternative for immunomodulation in sepsis?
    Robertson MS
    Crit Care Resusc; 2006 Sep; 8(3):235-8. PubMed ID: 16930112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of heparin in sepsis: much more than just an anticoagulant.
    Li X; Ma X
    Br J Haematol; 2017 Nov; 179(3):389-398. PubMed ID: 28832958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highlighting the potential of heparin in the treatment of sepsis in view of failure of KyberSept and OPTIMIST projects].
    Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):134-7. PubMed ID: 17376263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation and sepsis: the opportunity for a new use of heparin?].
    Jaimes F; de la Rosa G
    Biomedica; 2006 Mar; 26(1):150-60. PubMed ID: 16929913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of early administration of low-dose heparin in patients with severe sepsis].
    Zhang XJ; Ma XC
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1209-11. PubMed ID: 17147870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation during sepsis in organ transplanted children.
    Angele MK; Loehe F; Faist E
    Minerva Pediatr; 2005 Oct; 57(5):259-68. PubMed ID: 16205609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of heparin and allied compounds in the treatment of sepsis.
    Cornet AD; Smit EG; Beishuizen A; Groeneveld AB
    Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis.
    Walley KR; Russell JA
    Crit Care Med; 2007 Jan; 35(1):12-7. PubMed ID: 17080006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.
    Shapiro N; Howell MD; Bates DW; Angus DC; Ngo L; Talmor D
    Ann Emerg Med; 2006 Nov; 48(5):583-90, 590.e1. PubMed ID: 17052559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
    Kumar V; Sharma A
    J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C and the ovarian hyperstimulation syndrome: possible therapeutic implications.
    Hitkari JA; Rowe TP; von Dadelszen P
    Med Hypotheses; 2006; 66(5):929-33. PubMed ID: 16434147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
    Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
    Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
    Eid A; Wiedermann CJ; Kinasewitz GT
    Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.